Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance. - Wikidata - wikimedia - TriplyDB

Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.

Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.

http://www.wikidata.org/entity/Q34796700

about

Xanthine oxidase inhibition by febuxostat attenuates stress-induced hyperuricemia, glucose dysmetabolism, and prothrombotic state in mice Renin inhibition improves metabolic syndrome, and reduces angiotensin II levels and oxidative stress in visceral fat tissues in fructose-fed rats.Dipeptidyl Peptidase-4 Regulates Hematopoietic Stem Cell Activation in Response to Chronic Stress.Regulation and Functions of the Renin-Angiotensin System in White and Brown Adipose Tissue.Adipose Tissue-Derived Plasminogen Activator Inhibitor-1 Function and Regulation.

P2860

Q33683082-543EC7FC-CF39-459F-8C36-840FB4864DD7 Q33897671-3BD2E523-19C0-482D-A343-AE72DF839F9C Q38657340-FFA65BC6-65DE-40D1-B80E-D7ED422A9ECB Q47795975-051CB9D7-FFBE-4BA9-8108-A3A9F940C675 Q51361802-733D0251-88DD-4D13-A5BF-C0D42716CECF

P2860

Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.

http://www.wikidata.org/entity/Q34796700

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Angiotensin II receptor blocke ...... mation and insulin resistance.

@ast

Angiotensin II receptor blocke ...... mation and insulin resistance.

@en

Angiotensin II receptor blocke ...... mation and insulin resistance.

@nl

type

label

Angiotensin II receptor blocke ...... mation and insulin resistance.

@ast

Angiotensin II receptor blocke ...... mation and insulin resistance.

@en

Angiotensin II receptor blocke ...... mation and insulin resistance.

@nl

prefLabel

Angiotensin II receptor blocke ...... mation and insulin resistance.

@ast

Angiotensin II receptor blocke ...... mation and insulin resistance.

@en

Angiotensin II receptor blocke ...... mation and insulin resistance.

@nl

P1433

Q34796700-A94CE9D6-6AF5-43EE-B139-C1C0F46DC3CC

P1476

Q34796700-5DA7A9C9-C0DA-4D1D-A1D7-A6FB60F687DF

P2093

Q34796700-0630E388-2F9D-4D6F-8E10-607201568A25

Q34796700-1CCCC0DB-E801-445A-9FBF-30B1473DE1A8

Q34796700-3DCCC025-E681-43D1-92C2-B87B50C53512

Q34796700-520DD2F7-010E-4827-A26D-31C404C5F5A2

Q34796700-89A9763D-715E-41E5-A27E-FE0A3F837919

Q34796700-B6EF32E9-EE12-4E87-9DC3-9613A4639266

Q34796700-BC298A3C-0D75-45F7-8132-3A0469FEA5BD

Q34796700-F1D291D3-ED47-4030-963A-D0C51DC1D4F5

Q34796700-F57EEB5D-0F53-4E7F-AF0D-85A2CB1CB48A

Q34796700-FC5F0428-B042-420A-88B9-DA55EAC3A348

P2860

Q34796700-0230403A-0BBB-4977-86A7-12902DE0DE71

Q34796700-08105F35-50F1-4C64-BEB1-600397DD8D5B

Q34796700-0AF3DC92-C5BD-4E1D-9A67-ADAB32D88780

Q34796700-0F74CB95-82A5-4DDF-976E-14AA6FDC8798

Q34796700-14177E58-F8F1-426D-A837-3E1475824E4C

Q34796700-151C08FA-7EE4-49F5-9F95-900AC138F4B6

Q34796700-2944FDE2-788C-4059-AAF1-F18BFEACF99C

Q34796700-343C42C2-E282-40A0-9F44-22A67EB40FC8

Q34796700-3FDC78B0-7180-4E03-AEBC-BCE2E9F7C02F

Q34796700-41AFC817-9D46-45BE-BCDE-4CFBDBD4093F

P304

Q34796700-794A27FB-D6A8-4644-A523-9A2333CFB99A

P31

Q34796700-D9614C41-8ACD-41C4-95C3-E1866CF8D63F

P356

Q34796700-B79E35DE-D97B-45EA-B058-3C8DB58A49C4

P407

Q34796700-1763484A-3EBE-4701-AF92-F522CC93FAFF

P433

Q34796700-1EE63677-CBD8-48F1-9783-AAFCD01D469C

P478

Q34796700-7867815B-7FF4-4798-BCCE-5CB2D21BCC47

P50

Q34796700-180DBBC6-CD43-459E-A4CB-CB47862811AD

P577

Q34796700-B40EE1AD-1A21-41AC-B9F4-66D5920ED26A

P5875

Q34796700-80A24441-CC98-41A9-974C-01616C6B421D

P698

Q34796700-83368E8D-2F24-4091-A343-B2E7A7BCE566

P932

Q34796700-233EEB9A-9213-44A8-894E-F558CDC091F3

P356

JOURNAL.PONE.0116163

P1433

P1476

Angiotensin II receptor blocke ...... mation and insulin resistance.

@en

P2093

Emiko Nomura

http://www.w3.org/2001/XMLSchema#string

Koji Yamamoto

http://www.w3.org/2001/XMLSchema#string

Motoharu Hayashi

http://www.w3.org/2001/XMLSchema#string

Ryosuke Kikuchi

http://www.w3.org/2001/XMLSchema#string

Shigeo Nakamura

http://www.w3.org/2001/XMLSchema#string

Tadashi Matsushita

http://www.w3.org/2001/XMLSchema#string

Takayuki Nakayama

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

Xian Wu Cheng

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Uchida

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and adipokines: effects on sympathetic overactivity

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy.

Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.

Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity.

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis.

A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.

White adipose tissue: getting nervous.

Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.

The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome

P304

e116163

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0116163

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Kyosuke Takeshita

P577

2014-12-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270289689

http://www.w3.org/2001/XMLSchema#string

P698

25551221

http://www.w3.org/2001/XMLSchema#string

P932

4281136

http://www.w3.org/2001/XMLSchema#string